|
Market Closed -
Nasdaq
04:00:00 2026-10-23 pm EDT
|
5-day change | 1st Jan Change | ||
| 64.53 USD | -1.19% |
|
+3.70% | +47.23% |
| Oct. 09 | Exelixis' Zanzalintinib Clinical Trials for Cancer Highly Likely to Succeed, RBC Says | MT |
| Oct. 09 | RBC Raises Price Target on Exelixis to $51 From $45, Keeps Sector Perform Rating | MT |
Chart: Technical Analysis
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| EXEL | Delayed | |
CBOE
| EXEL | Real-time | |
|
Börse Stuttgart
| EX9 | Delayed | |
|
Borsa Italiana
| 1EXEL | End-of-day quote | |
|
Berne S.E.
| EX9 | End-of-day quote | |
|
Tradegate
| EX9 | Real-time | |
|
Boerse Muenchen
| EX9 | Real-time | |
|
Deutsche Boerse AG
| EX9 | Delayed | |
Sao Paulo
| E2XE34 | Delayed |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bullish | Bullish | Bullish |
| Resistance | 65.31 | 65.31 | 68.34 |
| Spread/Res. | -1.19% | -1.19% | -5.58% |
| Spread/Supp. | +6.01% | +18.51% | +25.94% |
| Support | 60.87 | 54.45 | 51.24 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- EXEL Stock
- Charts Exelixis, Inc.
Select your edition
All financial news and data tailored to specific country editions
